Jeff Johnson
Stock Analyst at Robert W. Baird
(4.51)
# 1,094
Out of 5,058 analysts
620
Total ratings
49%
Success rate
9.5%
Average return
Main Sectors:
Stocks Rated by Jeff Johnson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALGN Align Technology | Downgraded: Hold | $218 → $162 | $147.31 | +9.97% | 67 | Oct 15, 2026 | |
| NVST Envista Holdings | Downgraded: Hold | $34 → $26 | $22.90 | +13.54% | 39 | Oct 15, 2026 | |
| HSIC Henry Schein | Reiterated: Buy | $109 | $86.38 | +26.19% | 58 | Oct 9, 2026 | |
| BBNX Beta Bionics | Reiterated: Hold | $14 → $16 | $16.39 | -2.38% | 8 | Sep 15, 2026 | |
| COO The Cooper Companies | Downgraded: Hold | $85 → $61 | $57.94 | +5.28% | 56 | Sep 10, 2026 | |
| XRAY DENTSPLY SIRONA | Reiterated: Hold | $14 → $15 | $8.57 | +75.03% | 54 | Aug 7, 2026 | |
| PODD Insulet | Reiterated: Buy | $248 → $175 | $141.10 | +24.03% | 46 | Aug 6, 2026 | |
| ZBH Zimmer Biomet Holdings | Reiterated: Hold | $92 → $104 | $94.98 | +9.50% | 38 | Aug 6, 2026 | |
| DXCM DexCom | Reiterated: Buy | $80 → $105 | $86.04 | +22.04% | 61 | Jul 31, 2026 | |
| INMD InMode | Reiterated: Hold | $14 → $17 | $14.16 | +20.06% | 39 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $37 | $19.59 | +88.87% | 15 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 79.05 → CHF 74.89 | CHF 54.74 | +36.82% | 33 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $437 → $385 | $294.66 | +30.66% | 37 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $18 → $30 | $16.24 | +84.73% | 60 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $44.39 | n/a | 1 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $67 | $2.49 | n/a | 1 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $42 → $49 | - | n/a | 6 | Dec 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $99.70 | n/a | 1 | Apr 11, 2016 |
Align Technology
Oct 15, 2026
Downgraded: Hold
Price Target: $218 → $162
Current: $147.31
Upside: +9.97%
Envista Holdings
Oct 15, 2026
Downgraded: Hold
Price Target: $34 → $26
Current: $22.90
Upside: +13.54%
Henry Schein
Oct 9, 2026
Reiterated: Buy
Price Target: $109
Current: $86.38
Upside: +26.19%
Beta Bionics
Sep 15, 2026
Reiterated: Hold
Price Target: $14 → $16
Current: $16.39
Upside: -2.38%
The Cooper Companies
Sep 10, 2026
Downgraded: Hold
Price Target: $85 → $61
Current: $57.94
Upside: +5.28%
DENTSPLY SIRONA
Aug 7, 2026
Reiterated: Hold
Price Target: $14 → $15
Current: $8.57
Upside: +75.03%
Insulet
Aug 6, 2026
Reiterated: Buy
Price Target: $248 → $175
Current: $141.10
Upside: +24.03%
Zimmer Biomet Holdings
Aug 6, 2026
Reiterated: Hold
Price Target: $92 → $104
Current: $94.98
Upside: +9.50%
DexCom
Jul 31, 2026
Reiterated: Buy
Price Target: $80 → $105
Current: $86.04
Upside: +22.04%
InMode
Jul 14, 2026
Reiterated: Hold
Price Target: $14 → $17
Current: $14.16
Upside: +20.06%
May 8, 2026
Reiterated: Buy
Price Target: $45 → $37
Current: $19.59
Upside: +88.87%
May 7, 2026
Reiterated: Buy
Price Target: CHF 79.05 → CHF 74.89
Current: CHF 54.74
Upside: +36.82%
May 1, 2026
Reiterated: Buy
Price Target: $437 → $385
Current: $294.66
Upside: +30.66%
Dec 16, 2025
Upgraded: Buy
Price Target: $18 → $30
Current: $16.24
Upside: +84.73%
Dec 21, 2023
Reiterated: Buy
Price Target: n/a
Current: $44.39
Upside: n/a
May 5, 2023
Reiterated: Buy
Price Target: $67
Current: $2.49
Upside: n/a
Dec 4, 2017
Reiterated: Hold
Price Target: $42 → $49
Current: -
Upside: n/a
Apr 11, 2016
Reiterated: Hold
Price Target: n/a
Current: $99.70
Upside: n/a